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Abstract State systems are a rich, albeit challenging,
laboratory for policy-relevant services research studies.
State mental health authorities routinely devote resources
to collect data for state planning and reporting purposes.
However, these data are rarely used in cross-state comparisons to inform state or federal policy development. In
2008, in response to key recommendations from the
National Institute of Mental Health (NIMH) Advisory
Council’s ‘‘The Road Ahead: Research Partnership to
Transform Services,’’ (http://www.nimh.nih.gov/about/
advisory-boards-and-groups/namhc/reports/road-ahead.pdf),

NIMH issued a request for applications (RFA) to support
studies on the impact of state policy changes on access,
cost, quality and outcomes of care for individuals with
mental disorders. The purpose of the RFA was to bridge the
divide between research and policy by encouraging
research that used state administrative data across states,
and to address significant state-defined health policy initiatives. Five projects involving eight states were selected
through peer review for funding. Projects began in 2009
and were funded for 3 years. This report provides a brief
description of the five projects, followed by an analysis of
the impact, challenges, and lessons learned from these
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policy-partnered studies. We conclude by offering suggestions on ways to use state administrative data for
informing state health policies, which is especially timely
given national and state changes in the structure and
financing of healthcare.
Keywords

States  Mental health  Policy  Systems

State mental health systems routinely collect data for state
planning and reporting purposes. All states collect Medicaid data and utilization data for reimbursement that can
be used for quality improvement. States are required to
report data for special populations served. Many states
collect additional data through other systems such as child
welfare, corrections, aging, housing, and education programs. In addition, there are administrative data collected
through federal agencies [e.g., Centers for Medicare &
Medicaid Services (CMS), Social Security Administration
(SSA), Substance Abuse and Mental Health Services
Administration (SAMHSA), Centers for Disease Control
and Prevention (CDC), and Department of Justice (DOJ)]
that are available for analyses. Given the vast amount of
data and the cumbersomeness of combining data across
these entities, such data may be underutilized in the
development and monitoring of mental health policies.
This is unfortunate because state systems are a fertile if
challenging laboratory for policy-relevant services research
studies. Such studies can test the impact of policy decisions
on health services delivery. Using these data to not only
inform but to create a set of evidence-based policies has
immediate, almost intuitive appeal to policy-makers and
healthcare decision-makers (Goldman et al. 2001).
In the development of public policies about healthcare
services, however, research evidence can be secondary to
interests such as advocacy, political initiatives, media stereotypes, and public opinion (Bowen and Zwi 2005; Dobrow
et al. 2004; Waddell et al. 2005). Competing interests are
often overlooked in studies examining the use of research
evidence by policy-makers (Lomas and Brown 2009). Furthermore, the question of what kind of evidence or information policy-makers actually draw upon when making
decisions has been largely unaddressed by researchers (Hyde
et al. in press; Soydan and Palinkas 2014).
State mental health systems face an increasingly
uncertain environment in which to develop healthcare
policies, as the pressures to regulate and manage mental
health services are constrained by tighter budgets, changing
federal rules, smaller allocation of funds through block
grants, and ambiguities about the implementation of the
Patient Protection and Affordability Care Act (ACA),
passed in 2010 (Hoagwood et al. 2014). State responses to
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these changes are highlighting the importance of using data
systematically to drive healthcare service delivery and
decision-making (Gray 2013; Kazdin 2013; Kazdin and
Rabbitt 2013; Kelleher 2010). For example, states are
struggling with ways to integrate data across their systems
and to identify quality indicators for use in monitoring
processes and outcomes of care as part of quality
improvement initiatives (Institute of Medicine, Committee
on Quality of Health Care in America 2006; Institute of
Medicine, Committee on Science, Engineering, and Public
Policy, National Academy of Sciences, National Academy
of Engineering, 2009; Institute of Medicine, Committee on
Quality of Health Care in America 2000).
In 2008, in response to key recommendations from the
NIMH Advisory Council’s ‘‘The Road Ahead: Research
Partnership to Transform Services,’’ (http://www.nimh.nih.
gov/about/advisory-boards-and-groups/namhc/reports/
road-ahead.pdf), NIMH issued an RFA (RFA-MH-09-050)
to support studies on the impact of state policy changes on
access, cost, quality and outcomes of care for individuals
with mental disorders. The purpose of the RFA was to
bridge the gap between research and policy. The RFA
required applicants to build their proposed studies around
four design considerations that differentiated these studies
from typical academic research. First, applicants were
required to apply jointly, with one principal investigator
representing a state policy perspective, and the other
principal investigator a university-based researcher. Second, two states had to be included for comparison purposes. Third, applicants were required to use existing
administrative data; no new data collection was authorized
so as to reduce costs, model the use of existing administrative data, and, in principle, produce more timely findings. Fourth, each project had to identify study aims that
addressed significant mental health policy questions of
interest to the host state mental health authority, not just to
the researchers, with a research plan that was methodologically rigorous and able to meet peer-review standards.
Five projects were selected for funding through peer
review. In this report, the grantees provide a brief
description of the five projects, including goals, methods,
and their policy or program impacts. In addition, we share
the challenges and lessons learned across studies. We
conclude by offering suggestions about ways to use state
administrative data to inform the kinds of healthcare policy
assessments envisioned by the Patient Protection and
Affordability Care Act (ACA). Some of the projects’
findings already have undergone peer review, and in those
cases, we cite the relevant publications. Other findings are
summarized here prior to submission for peer review,
hence must be interpreted with appropriate caution.
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Project Overviews

Methods

The five projects involved eight states, with comparisons
between two states in each project (two projects involved
the same two states). Projects began in 2009 and were
funded for 3 years; see Table 1 for a summary of studies,
methods, major findings, and impacts. The projects differed
in terms of populations targeted, data sets used, degree to
which the data could be merged, and type of state policy
addressed. All of the projects used Medicaid data; in six
states, Medicaid data were accessed directly, whereas in
SC and WA, databases were used that included Medicaid
data. Medicaid data are available in all states and they
allow examination of service use across time, providers,
and service modalities in ways that would be difficult to
determine from other data sources.

Three distinct Medicaid policies were implemented from
2002 to 2009 on sedative hypnotics: patient cost-sharing,
prescriber quantity refill limits, and preferred drug list
status/prescriber prior authorization. Retrospective cohorts
were created for patients with serious and less severe
diagnosed mental illness who met inclusion criteria.
Medicaid prescription drug fill claims and eligibility rates
by age group and year were acquired for analysis using
multivariate methods and time series with segmented
regression. Second generation antipsychotics were measured in both states with particular attention to low-dose
quetiapine because of its off-label use as a sleep aid.

CO-OR

CO and OR baseline rates of psychotropic medication use
were substantially different, perhaps because of lessrestrictive access policies and attitudes about mental health
treatment in OR. Nearly two-thirds of quetiapine use fell
below recommended dosing levels, suggesting off-label
use for insomnia. Trends in OR suggested reduction in lowdose use after policies were implemented to curb use of
antipsychotics for insomnia. Time series analyses of three
alternative access restriction policies using segmented
regression (unpublished study) found cost-sharing and
prior authorization were associated with significant changes in aggregate utilization. Quantity limits alone were not
associated with reduced prescription use of newer sedative
hypnotics (Campbell et al. 2013; Hartung et al. 2012,
2014).

Libby and Zerzan used Colorado and Oregon Medicaid
claims data to measure the extent to which Medicaid prescription drug policies reduced the use of newer sedative
hypnotics and increased the unintended use of low-dose
second generation atypical antipsychotics (SGA) as possible sedative substitutes. This was an important issue
because low-dose antipsychotics may be used off-label
(i.e., for other than a Food and Drug Agency (FDA) indication) despite more frequent side effects, compared to
other drugs used for insomnia. Using a retrospective, quasiexperimental, difference-in-differences design, the study
measured baseline trends, and isolated policy impacts on
sedative hypnotic utilization across states and over time for
patient subpopulations. The study rationale came from
discussions with states participating in the Drug Utilization
Review Project (DURP), who expressed concern about the
use of sedatives for people with mental illness, and inappropriate use of anti-psychotics for insomnia. Both Colorado and Oregon manage prescription drug coverage using
preferred drug lists (PDL). PDLs are like managed formularies in that a committee assesses evidence and advises
Medicaid on the medications that should be made available
for current practice, based on evidence, FDA indication,
and costs. Unlike private health plans with managed formularies, Medicaid cannot have a formulary with discrete
limitations on access to medications. Medicaid PDLs list
medications to be used first within a drug class (i.e., firstline therapy) with no restrictions on prescription drug
coverage. PDLs use policies to influence prescription drug
use such as requiring a prescriber to obtain prior authorization, or to prescribe in limited quantities, and patienttargeted PDL policies such as cost-sharing (higher copayments for non-preferred drugs).

Key Findings

Policy Impact
Colorado used this information in refining its PDL and
prior authorization policies, and to identify drug classes in
which drug utilization review could be helpful to prescribers and clients. Oregon also used this information to
refine its policies around sedative-hypnotics and antipsychotics, and to identify areas in need of further evaluation.
The finding of wide variation in prescribing across these
two states has led both states to further investigate potential
causes of variation (Zerzan et al. 2011).
GA-SC
Narasimhan and Druss examined the impact of a statewide
telepsychiatry program on use of emergency services and
costs of services in Georgia and South Carolina. The state
initiative targeted for this study was the introduction of
telepsychiatry as a new service modality to address the
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Table 1 Summary of NIMH R01 grants funded under RFA-MH-09-050 ‘‘Use of Pooled State Administrative Data for Policy Relevant Mental
Health Services Research’’
Pooled
states

Principal
investigators

Grant title

Research aims

Datasets

Outcome
indicators

Key findings

CO-OR

Zerzan and
Libby

Sedative hypnotic
use by the
mentally ill: A
Medicaid
prescription
policy study

Develop a pooled, multistate Medicaid dataset to
study changes in health
service utilization
associated with policy
implementation of sedative
hypnotic access restriction
policy types (preferred
drug lists, prior
authorization and cost
sharing) in CO and OR

Medicaid

Prescriptions of
psychotropics,
second
generation
antipsychotic
(SGA)

Quetiapine was the most
frequent SGA in both
states (40 % new starts),
and for low-dose SGA new
starts (55 % CO, 63 %
OR). Females had an
increased likelihood, and
people diagnosed with
schizophrenia or anxiety
had a decreased likelihood
of low-dose quetiapine
initiation. Initiation of
low-dose quetiapine as a
proportion of all SGA
initiation and or of
quetiapine starts
significantly decreased
after off-label promotion
ended in one state (OR).
Cost sharing and Preferred
Drug Lists were associated
with decreased utilization,
but quantity limits were
not associated with
significant change in
prescription rates in both
states

Assess the impact of
expedited Medicaid
benefits restoration
policies on service
utilization and costs
among persons with severe
mental illness

Medicaid

CTWA

Morrissey
and Frisman

Community
reentry of
persons with
severe mental
illness released
from state
prison

Prescription drug,
service
utilization, and
expenditure
Speed and duration
of policy impact
on sedative
hypnotic and
SGAprescription
fills

Mental health
service (inpatient
and outpatient)
use
Substance use
Arrest and
incarceration
Cost

GA-SC

NY-PA

Narasimhan
and Druss

Essock,
Donahue
and Stein

Clinical and
policy
implications of
a statewide
emergency
telepsychiatry
program

Evaluate the impact of a
statewide telepsychiatry
intervention in emergency
departments on service
utilization and costs

Medicaid

Evaluating the
impact of
clinical alerts
generated from
Medicaid
claims data

Using Medicaid claims data
to generate clinical flags
predicting short-term risk
of continued psychiatric
hospitalizations

Medicaid

All-payor,
health
data
warehouse

Inpatient
admission
Outpatient followup
Total cost
Psychiatric
hospitalization
Outpatient service
use
Psychotropic
prescription
Cost of service
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Inmates with severe mental
illness who received
expedited Medicaid
benefits were more likely
to access mental health
services and have shorter
time without insurance
coverage; no significant
effects in criminal justice
outcomes and costs
Intervention state had low
rates of inpatient
admission, lower costs,
and higher rates of
outpatient follow-up than a
matched control state
Multiple recent
hospitalizations
significantly predicted
high short-term risk of
continued frequent
hospitalizations, but
absence of recent
medication fills and
absence of recent
outpatient services did not
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Table 1 continued
Pooled
states

Principal
investigators

Grant title

Research aims

Datasets

Outcome
indicators

Key findings

NY-PA

Wisdom,
Hoagwood,
Finnerty
and Stein

Quality
improvement
implementation
in child mental
health: A 2-state
comparison

Evaluate the impact of a
statewide continuous
quality improvement
initiative for psychotropic
polypharmacy and the
effects of prior
authorization policies on
antipsychotics
psychotropic prescription
among children and
adolescents

Medicaid

Psychotropic
polypharmacy

Polypharmacy patterns were
associated with bipolar
disorder, older age,
specialty mental health
services; polypharmacy
decreased following clinic
participation in the
continuous quality
improvement initiative;
prior authorization policies
had a modest but
statistically significant
effect on decreased
antipsychotic use in
children aged 6–12

shortage of psychiatric providers and also access to care in
rural counties
Methods
Individuals treated via telepsychiatry were matched to
individuals treated for mental health diagnoses in nonparticipating hospitals within South Carolina. Regression
models were used to assess differences in outpatient follow
up, admission following the emergency department (ED)
visit, length of stay, inpatient, and total costs.
Key Findings
As compared with the control group, the telepsychiatry
group was more likely to have successful outpatient mental
health follow-up, lower odds of admission and length of
stay for the index visit, and lower 30-day inpatient costs
than the matched controls.

Area
Resource
File

Antipsychotics
prescription

illnesses. The purpose of this study was to test the development of claims-based performance measures that could
be built into future contracts for managed care to incentivize the engagement of persons in services post-hospitalization, to prevent rapid re-hospitalizations, and to
target alternative, less- intensive and less-costly services
for state implementation. The study tested how well patterns of service use predicted subsequent high short-term
risk of continued psychiatric hospitalizations.
Methods
Medicaid claims files were used to identify Medicaid
recipients, aged 18–64, with two or more inpatient psychiatric admissions during a target year ending March 31, 2009.
Definitions from a quality-improvement initiative were used
to identify patterns of inpatient and outpatient service use
and prescription fills suggestive of clinical concerns. Generalized estimating equations and Markov models were
applied to examine claims through March 2011.

Policy Impact
Key Findings
The findings of improved access enabled the state to make
a strong business case for expansion of telepsychiatry. Blue
Cross and Blue Shield of South Carolina became champions in leading the way to reimburse telehealth because it
would increase access to specialty care for its members.
Sustainability efforts are underway.
NY-PA: Data from Adults
Essock, Donahue, and Stein studied the feasibility and
impact of clinical flags developed within Medicaid claims
data for New York and Pennsylvania to predict the risk of
psychiatric hospitalizations for adults with severe mental

Analyses demonstrated that claims data on prior psychiatric hospitalizations can identify Medicaid-enrollees disengaged from treatment (Smith et al. 2014; populations at
higher risk of not re-engaging in treatment (Smith et al.
2014), and populations at unusual risk of continued frequent hospitalizations (Stein et al. 2014a, b). Further, as
few as 4 months of recent claims data are sufficient for this
purpose. Multiple recent hospitalizations, but not failure to
use outpatient services nor failure to fill medication prescriptions, were significant predictors of high risk of continued frequent hospitalizations, with odds ratios greater
than 4.0 (Stein et al. 2014b).
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Policy Impact
New York State now routinely uses administrative data to
identify individuals at high risk of continued frequent
hospitalizations. The NY and PA findings suggested that
utilizing recent service use data to identify individuals most
in need of services helps to break the cycle of continuing
rapid psychiatric readmissions. The NY and PA findings
also led to the development and testing of algorithms to
avoid determining service eligibility based solely on past
service use.
NY-PA: Data from Children and Youth
Wisdom, Hoagwood, Finnerty, and Stein examined the
impact of state-level interventions to improve the quality of
psychotropic medication prescribing among publically
insured children in NY and in PA. The significant increase
in the use of psychotropic medication among children,
including increased use of antipsychotics and multiple
concurrent medications, raised quality concerns for both
states (Essock et al. 2009; Medicaid Medical Directors
Learning Network 2010; Kealey et al. 2014). NY engaged
mental health clinics in a health information technology
(HIT) supported (PSYCKES-Medicaid) continuous quality
improvement (CQI) initiative to facilitate reduction of
psychotropic polypharmacy among children, and PA
introduced a prior authorization policy for the use of
antipsychotic medications in children.
Methods
The CQI intervention study identified children who
received mental health clinic services in New York
between 2006 and 2011 and used joinpoint regression
analyses to model trends in polypharmacy use among
children in CQI participating versus non-participating
clinics (Wisdom et al. 2012). The prior authorization study
examined the effect of the prior authorization policy on the
proportion of Medicaid-enrolled children on antipsychotic
medications in PA using a triple-difference strategy
including differences between PA and NY, where there
was no prior authorization policy; time periods (before and
after the introduction of the prior authorization policy in
PA), and differences in antidepressant prescribing rates
over the same time periods (to control for secular trends in
psychotropic prescribing) (Stein et al. 2014a).
Key Findings
In NY, a significant shift in polypharmacy trends occurred
in the year following the CQI project launch with a significant decrease in use of psychotropic polypharmacy
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among children in participating clinics, while children in
non-participating clinics had a significant increase in use of
polypharmacy over the study period. In the prior authorization study, policies were associated with a small but
significant reduction in antipsychotic prescribing for children 6–12, but had no impact among 0–5 year olds.

Policy Impact
The results of the CQI study suggest that mental health
clinics can be successfully engaged in a large scale, HITsupported quality collaborative and change prescribing
practices for children. These findings, along with similar
results for adults, supported the continuation and expansion
of the HIT CQI program in NY to other quality measures
and settings. Further, this approach has been expanded to
other states through an Agency for Healthcare Research
and Quality funded multi-state quality collaborative
(Finnerty et al. 2014). The prior authorization study highlighted that this commonly-used pharmacy benefit management strategy may not work for all populations and
medications.
WA-CT
Morrissey and Frisman examined expedited Medicaid
benefits programs in Washington State and Connecticut for
released prisoners with severe mental illness. Both states
had developed initiatives to improve mental health outcomes and reduce recidivism among released prisoners
with severe mental illness. The goal of the study was to
assess the impact of expediting benefits on post-prison
Medicaid access and uptake, hospitalizations, use of outpatient mental health and substance abuse services, criminal recidivism (re-arrests, jail days, prison incarcerations),
and costs.

Methods
A quasi-experimental design was used to compare outcomes for prisoners with severe mental illness who
received expedited benefits with a control group of prisoners with severe mental illness who did not receive
expedited Medicaid. Propensity score weighting was used
to balance treatment and control groups on observed
baseline demographic and clinical characteristics and
behavioral health and criminal justice utilization during a
3-year pre-release period. Linked, administrative data from
multiple public sectors were used, and offenders with
severe mental illness were followed for up to 36 months
after release from prison.

Adm Policy Ment Health (2016) 43:67–78

Key Findings
In both WA and CT, expedited Medicaid was associated
with a greater probability of accessing Medicaid, and
quicker Medicaid access after prison release. In addition,
expedited Medicaid was associated with a greater probability of accessing mental health services, and quicker
access to mental health and medical services. However,
there was no effect on criminal justice outcomes as more
than 50 % of participants in both groups had at least one rearrest in the 12 months following index release.
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to stakeholders, to assess hypotheses and interpretations,
and to stay abreast of emerging initiatives, fostered
engagement between policymakers and researchers and
helped ensure that the approaches undertaken would yield
findings relevant to that state.
The authors of this paper identified a set of important
issues that arose at the system interface of these studies
involving state policy and academic research. The issues
described below are simultaneously methodologic,
administrative, and substantive. We outline these below as
a guide for future policy-relevant studies using state
administrative data.

Policy Impact
Findings suggest that Medicaid improves mental health
service use, but alone, might not be enough to keep prisoners with severe mental illness out of the criminal justice
system. Nationally, the implications for the expansion of
the Affordable Care Act to justice-involved populations is
that simply adding offenders to the Medicaid roles may not
be enough to reduce their criminal recidivism. The project
also shaped both policy and new research at the state-level,
especially in Connecticut, where the state found support for
arranging Medicaid benefits for mentally ill prisoners prior
to their release, which meant that the program has been
sustained. Further, the project demonstrated to stakeholders
the value of interagency data mining, supported the
expansion of services beyond Medicaid for transitioning
prisoners, and facilitated new studies using interagency
data.

Discussion
These projects are examples of the yield that can be
expected when state policy leadership and services
researchers bring their expertise to bear on policy-relevant
questions. Given the profound shifts in state mental health
policies as more and more states move to managed care
(National Association of State Mental Health Program
Directors Research Institute, Inc. 2012), and the restructuring occasioned by healthcare reform, such partnerships
will be even more useful for informing state planning and
policy making.
These projects were structured as academic-policy
partnerships and incorporated ongoing collaborations, frequent communications, and delineation of responsibilities,
roles, and partnered decision-making. These partnerships
allowed the academic partner to become expert in the
complexities, opportunities, and shortcomings of state data
files, and the state partner to have the benefit of working
with researchers to support development of data-driven
policymaking. Having opportunities to feed findings back

Data Quality
All of the studies used state Medicaid data. As these data
are collected for administrative rather than research purposes, researchers had to develop a comfort level in
working with information where, often, only approximate
answers can be arrived at, even with regard to pressing
policy issues. The usability of Medicaid data for policy
research varies by state, and researchers need to be aware
of the quality of the individual state data they are working
with (Byrd and Dodd 2012, 2013). In addition, Medicaid
and other claims data are imperfect in that they provide
limited information from which to make inferences about
the content or quality of services, results of tests, or outcomes of services; in addition, the diagnostic information is
generated from routine clinical and billing practices, not
research diagnostic interviews. Medicaid claims data
reflect service use, not need. In many states, the department
of mental health receives information on service use
(numerator), but not on the total population of users and
non-users (needed for a denominator), hence measures of
penetration (e.g., percentage of youth with a mental health
visit) can’t be computed.
In comparison to the Medicaid Analytic eXtract (MAX)
data maintained by the Center for Medicare and Medicaid
Services for policy research purposes, state Medicaid data
is more recent by 3 to 4 years, and in some states, is
available in nearly real-time. However, state Medicaid data
may not be cleaned and standardized across states, meaning
researchers need to invest significant time in preparing data
for analysis including data cleaning, variable testing, and
identifying convergence and divergence among databases
across states. For some projects, differences in database
quality or content for each two-state study created a great
deal of noise, making interpretation more complex.
Researchers needed to be flexible, in some cases adapting
their study questions or methods as they learned more
about the state databases with which they were working
(for in-depth discussion of innovative methodological
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approaches to state policy research, see Duan et al. 2014
and Palinkas et al. 2013).
These experiences speak to the value of including state
partners with intimate knowledge not only of state programs but the individual state administrative data files
relevant to the study to ensure feasibility and validity of
methods. Some projects here incorporated such state data
analysts from the outset. The grant projects allowed
researchers to become more familiar with individual state
databases, and laid the groundwork for future studies and
public-academic partnerships.
Because of the variability, state-to-state, in the generosity of Medicaid mental health benefits and regional
variation in treatment patterns, generalizability of the
findings from any of the state projects to all other states
would be problematic. There are also, of course, significant
variations in the demographic make-up of the populations
across states. Thus, the findings from any of these studies
may be applicable to a select number of other states that
could be matched on demographic patterns, financing,
generosity of benefits, etc. In the selection of state pairings,
all investigative teams sought to make meaningful contrasts so that the findings could be applicable to other
states. For example, some pairings (e.g., NY and PA) were
selected to contrast states with similar coverage. Strategic
consideration of the characteristics of the Medicaid benefit
package and of state differences needs to be made prior to
extrapolation of any of these findings.
Data Access and Linkage
Multi-system data linkage is easy to envision and difficult
to implement. Accessing state data and linking Medicaid
data with other state administrative data, or across state
Medicaid programs, requires a significant investment of
time for both the academic and state partners. Consistent
with other reports (Finnerty et al. 2014), in some states, it
took university-based investigators half of the 3-year study
timetable to develop acceptable data use agreements with
state agencies and their contracted data vendors (sometimes separately) to link files with Medicaid claims. In one
state, researchers found that key variables, such as eligibility, were not available at the individual level, and that
race/ethnicity or cross-system involvement were typically
not reported, with the net result that the interagency data
was of limited use. States or the federal government could
ameliorate this situation by creating the equivalent of
advance directives granting academic partners access to
such data in an accelerated way when the data will be used
for the state’s quality improvement purposes. Further,
states need to develop their capacity to track and study
populations via administrative data (e.g., from death
records, criminal justice, education) in addition to
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Medicaid so that, when linked to claims data, the composite data will enhance the generalizability and policy
relevance of study findings.
Investigators had a much easier time in data access and
linkage in states where there were data warehouses, or
where there were already-established relationships for
multi-agency studies. In Washington State, investigators
benefitted from access to a pre-existing data warehouse,
maintained by the state, that linked Medicaid claims with a
variety of other behavioral health and criminal justice data
systems. In Connecticut, these same data were assembled
through data use agreements negotiated by the principal
investigator, who was the long-term director of research for
the state behavioral health agency and an active participant
in an interagency data sharing network for multiple prior
research studies. In the South Carolina project, investigators were able to use an all-payor dataset as well as Medicaid data.
The take-away message about data access and linkage is
that states maintaining data warehouses and those with
established university-agency collaborations are better
positioned to conduct research using administrative data.
States that have invested their own resources in developing
university partnerships and data linkages across public
sector agencies to support evidence-based management
decisions are much better positioned to participate effectively in this type of policy research. Researchers interested
in establishing new public-academic partnerships should
plan for dedicated time to establish these data sharing
agreements and protocols. One benefit of grant-funded
public academic partnerships is that once established, data
access protocols are easier to expand and sustain, building
a foundation for future work (Finnerty et al. 2014).

Institutional Review Boards (IRB)
The inevitable consequence of attempting to link multiagency data is that human subject approvals have to be
obtained from multiple agency and university IRBs.
Ambiguity as to whether the studies were quality
improvement or research led to significant (i.e., up to
1 year) IRB approval delays for some groups.
Another factor contributing to research delays had to do
with the separation of state staff, who knew Medicaid
policies and procedures, from the people at contract organizations, who could read the data file, but knew little about
data definitions and codes. This led to discontinuity over
time, as some states changed data use agreements, and in
some cases, changed contracts about what data would be
made available to the researchers. It also led to a loss of
institutional memory pertaining to explanations for missing
data or spikes in measured observations. Job turnovers and
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staff changes in some states also led to interruptions in the
work.
Parallel Versus Pooled Analyses
Most of the projects had proposed combining the data from
the two comparison states to conduct a pooled analysis,
while others proposed parallel analyses from the outset.
The pooling of data across states can be cumbersome in the
absence of prior experiences with Medicaid and agency
coding, defining key parameters (service episodes, eligibility, etc.) consistently in each state, and employing
common algorithms to identify comparable samples. During study implementation, however, some state agencies
did not approve providing de-identified data to other states
for this purpose. As a result, some projects had to construct
parallel databases and then conduct separate, parallel
analyses. The two approaches—pooling the data or pooling
the findings—can lead to equivalent results as long as there
is careful alignment and specification of data elements,
codes, definitions, and other parameters. An advantage of
data pooling is a bump-up in statistical power, which might
be important in studies analyzing low-frequency events or
small samples. When agency policies prevent combining
data across states, or when such pooling would greatly
increase the cost and complexity of the task at hand,
pooling based upon separate, parallel analyses may be the
best and, perhaps only, recourse. In addition, given the
large variation observed within and between states, and the
challenges in using data across state systems, single state
studies should be considered.
Political Context
State systems are by nature embedded in an operating
environment heavily influenced by day-to-day political
realities. Change is not only ongoing, but also typically
driven by the dominant political culture of the time. Tensions can arise between the pressures of maintaining scientific rigor and meeting the demands of peer review
versus the necessity of responding to new policy pressures
or initiatives that might divert studies from intended aims.
These tensions reflect the different epistemologies and
cultures of science versus governing and policy-making.
The differing perspectives are an inevitable part of the
reality of this kind of academic-policy research partnership.
Even so, conducting rigorous research within a political
environment can be facilitated by clear communication and
understanding between state and academic partners as to
where compromises can and cannot be made on both sides.
It requires translation and back-translation between those
crafting policy, and those pursuing data-driven answers.
Tensions may arise when policymakers need to make quick
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policy decisions, yet researchers realize that study findings
are still emerging and that early findings may not pan out,
hence not ready to guide implementation. Policymakers
may feel that even preliminary findings offer them more
information than they usually have available to inform their
decisions. Researchers on the other hand, trained not to draw
conclusions early and to look to peer-reviewed publication
and confirming studies to increase confidence in conclusions, may feel very uncomfortable sharing preliminary
findings or having states act upon them. CQI is a framework
that may bridge state and research cultures, and lead to a
shared recognition that some questions cannot be answered
at all, many are not answered quickly, and that continuous
evaluation and review is needed to assess, in real-time, the
impact of quality improvement efforts. Frank, open, and
honest conversations among the partners about these different pressures help create strong partnerships and highimpact findings focused on state policy priorities.
Cui Bono?
It is appropriate in concluding this brief report to pose the
question as to who benefits from this type of research. We
believe that there are multiple benefits for different stakeholders from state policy research using administrative data.
Benefits accrue to the host states, to researchers committed to
developing an evidence-base that can be used to enhance the
health of people with severe mental illness or serious emotional/behavioral disorders, and even to the funding agency (in
this case, NIMH) for being able to demonstrate its utility in
informing state mental health policy (See Table 2). Although
the five projects profiled in this report focused primarily on
state-level policy issues, state administrative data can also be
used at the client, clinician, and program level to inform
clinical decision making and quality improvement (Finnerty
et al. 2011; PSYCKES-Medicaid 2014) or compare outcomes
of treatment interventions at the program level (Morrissey
et al. 2013), or at the population level to identify needs and
disparities, determine access, and target interventions to
address the needs of distinct populations in the mental health
and broader health and human services arena.
Given the publications to date, the current projects
demonstrate that grant applications relying on state administrative data can meet the rigors of scientific review. By
stimulating cross-state comparisons, federal research institutes or agencies, such as NIMH, can advance knowledge
about service system design, performance, and cost-outcomes; they can advance comparative effectiveness
assessments at policy, program, and population levels; and
they can advance its strategic plan. This type of research can
also position federal research agencies to capitalize on the
opportunities associated with the Affordable Care Act about
efficient service system redesigns.

123

76

Adm Policy Ment Health (2016) 43:67–78

Table 2 Who benefits from use of state administrative data in Policy/Program/Population Health Research?
Federal Research Institutes

States

Researchers

This research…

This research…

This research…

Responds to states and their identified
policy issues

Identifies what works for resource allocation
decisions

Advances policy/program/population-level
comparative effectiveness research

Assesses whether studies using state
administrative data can meet peerreview standards

Demonstrates how multiagency administrative
data can be organized and analyzed to answer
policy/program/population health questions and
helps advance state efforts to become learning
healthcare organizations

Illustrates how to design, measure and analyze
administrative data for policy/program/
population health issues

Stimulates cross-state comparisons to
advance knowledge about service
system design and performance

Fosters academic-state agency collaborations for
policy/program/population assessments and
gives states access to national experts focused on
state priorities

Makes research grant proposals more fundable by
using administrative data in lieu of costly
prospective data collection

Provides opportunities to support
research on delivery system
innovations under the Affordable
Care Act

Promotes continuous quality improvement to align
state and local service providers

Facilitates academic researchers’ understanding of
what topics have high policy significance to
states, and how to work with state officials to
carry out such research

Advances NIMH Strategic Plan

Identifies priority areas for strategic policy
development and management via creation of
evidence-informed policies

Affords researchers the opportunity to have their
work impact public mental health services

States, in turn, benefit from supported research done
collaboratively with university-based research teams on
topics salient to the state mental health authorities and
other agency stakeholders. These studies demonstrate how
data that states collect for their own administrative and
reimbursement purposes can also be used in a rigorous
scientific manner to answer questions about what works,
for whom, and under what circumstances. Academic partnerships can give states access to national experts focused
on questions that are a high priority for states. Importantly,
funding for this type of research fosters academic-state
agency collaborations that build state capacity to use their
data to conduct policy research, help advance state efforts
to become learning healthcare organizations, and facilitate
growth of a new generation of services research that will be
stimulated by the Affordable Care Act.
Lastly, researchers and the field of mental health services and policy research also benefit in important ways.
Studies using state administrative data will increasingly
become necessary, given declining budgets for services
research at the federal level, and reduction of funding for
prospective studies of service interventions such as those
conducted in the clinical trials tradition. This research
provides opportunities for researchers to apply the latest
developments in theory and methods with big data sets to
answer important questions with immediate relevance to
helping people with severe mental illness live more productive lives in their community. In addition, researchers
who demonstrate expertise in using state administrative
data to answer important questions at the program, population, or policy levels will be much more likely to succeed
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in the increasingly demanding world of competitive
research grant funding.

Conclusion
The use of state administrative data for generating evidence
about public policy issues is both scientifically and ethically
valuable. Our combined experiences in developing and
maintaining these state-academic partnerships demonstrate
that the research-policy-practice gaps that exist can be
bridged. We identified five issues that may arise when
conducting such studies. The challenges can be significant,
yet the yield from this kind of partnered research can have
immediate public health benefits. There is also an ethical
responsibility to benefit the public by facilitating access to
data generated with public dollars, using these data to
improve the quality of services for children and adults with
mental disorders, and applying the highest-quality scientific
methods to ensure accuracy and validity in the interpretations of analyses. States, in collaboration with academic
partners, create a fertile laboratory for such work.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
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